Quantcast
Last updated on April 16, 2014 at 14:14 EDT

Latest Microbicides for sexually transmitted diseases Stories

2013-06-30 04:20:10

New global report released at IAS 2013 highlights funding trends, opportunities and challenges for HIV prevention R&D KUALA LUMPUR, Malaysia, June 30, 2013 /PRNewswire-USNewswire/ -- Recent breakthroughs in HIV prevention research have confirmed the promise of new options to help end the AIDS epidemic and highlight the urgent need for ongoing research to develop additional prevention options and support rapid rollout of proven ones. However, continued progress requires a broader base...

2013-04-04 12:01:05

A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published today in PLOS ONE. The study, led by researchers with the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), tested a reduced glycerin formulation of tenofovir gel, and has spurred the development of an expanded safety study of the gel, expected to launch later this...

2013-03-13 04:20:31

MELBOURNE, Australia and TEL-AVIV, Israel, March 13, 2013 /PRNewswire/ -- Starpharma Holdings Ltd (ASX:SPL; OTCQX: SPHRY) and Makhteshim Agan Group today announced a collaboration program. This will see Starpharma's Priostar(R) dendrimer technology applied to novel crop protection formulations across Makhteshim Agan's extensive product portfolio. Makhteshim Agan is the world's leading manufacturer and distributor of branded off-patent crop and non-crop protection...

2013-03-04 12:28:38

VOICE Results Underscore Need for Clear, US-Based PrEP Implementation Agenda ATLANTA, March 4, 2013 /PRNewswire-USNewswire/ -- The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women's health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at...

2012-05-17 12:31:32

Reformulated gel could serve as an anti-HIV product for both vagina and rectum A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found that the reformulated gel was less harmful to the lining of the rectum than the original vaginal...

2012-04-19 20:59:50

Miriam Hospital researchers examine impact of user experience with topical vaginal gels Are women willing to use a vaginal gel to protect themselves against HIV infection? Researchers at The Miriam Hospital say that is the million dollar question when it comes to developing products known as microbicides that can prevent the sexual transmission of HIV. Now the findings of a new study known as Project LINK could offer critical insight on user experience with topical vaginal gels —...

2012-04-17 10:22:33

A newly launched African-inspired, African-led initiative says 'yes' to rectal microbicides Today IRMA (International Rectal Microbicide Advocates) will release "On the Map: Ensuring Africa's Place in Rectal Microbicide Research and Advocacy" at a special evening reception at the international Microbicides 2012 conference at the Sydney Convention and Exhibition Center. A cornerstone of IRMA's Project ARM (Africa for Rectal Microbicides) initiative, the strategy document developed by...

2012-04-16 21:35:58

Researchers, activists and funders are meeting this week in Sydney to discuss the state of HIV prevention research. The biennial International Microbicides Conference, which was opened on Sunday evening by the Honorable Tanya Plibersek MP, Australian Minster of Health, is taking place amid renewed optimism about development and delivery of new HIV prevention options with the potential for ending the AIDS epidemic, including anti-retroviral based microbicides and pre-exposure prophylaxis...

2011-03-07 14:16:18

Microbicides can be used to protect against HIV, and other sexually transmitted diseases, either on their own or with the added protection of a condom. New research published by BioMed Central's open access journal AIDS Research and Therapy has investigated the use of lubricants, originally designed for vaginal application, and has developed and tested new, rectal specific, formulations. Unprotected sex is one of the major ways that HIV spreads through the population. However most research...

2011-02-28 22:25:44

'New' gel safe and effective in laboratory studies A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests research presented today at the 18th Conference on Retroviruses and Opportunistic Infections (CROI). In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found the reformulated gel was less harmful to the lining of the rectum than the original vaginal formulation, and...